Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector
暂无分享,去创建一个
[1] J. R. Moore,et al. The theory of the growth of the firm twenty-five years after , 1960 .
[2] R. Rumelt. Towards a Strategic Theory of the Firm , 1984 .
[3] S. Winter,et al. An Evolutionary Theory of Economic Change.by Richard R. Nelson; Sidney G. Winter , 1987 .
[4] James M. Utterback,et al. Mastering the Dynamics of Innovation , 1996 .
[5] D. Teece,et al. DYNAMIC CAPABILITIES AND STRATEGIC MANAGEMENT , 1997 .
[6] D. Teece. Capturing Value from Knowledge Assets: The New Economy, Markets for Know-How, and Intangible Assets , 1998 .
[7] Kathleen M. Eisenhardt,et al. DYNAMIC CAPABILITIES, WHAT ARE THEY? , 2000 .
[8] S. Ramani,et al. A statistical examination of the integration of biotechnology in the Indian pharmaceutical sector , 2001 .
[9] S. Ramani. Who is interested in biotech? R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms , 2002 .
[10] S. Winter. Understanding dynamic capabilities , 2003 .
[11] D. Kale. Re-developing knowledge creation capability: Innovating in Indian pharmaceutical industry under the TRIPS regime , 2005 .
[12] P. Sampath. Indian Pharma Within Global Reach , 2006 .
[14] J. Pradhan. New Policy Regime and Small Pharmaceutical Firms in India , 2007 .
[15] Steve Little,et al. From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry , 2007, Technol. Anal. Strateg. Manag..
[16] Des Spence. The bitterest pill , 2007, BMJ : British Medical Journal.
[17] Geert Duysters,et al. Serving low-income markets: Rethinking Multinational Corporations’ Strategies , 2008 .